MOUNJARO

This brand name is authorized in Austria, Canada, Estonia, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Romania, United Kingdom, United States

Active ingredients

The drug MOUNJARO contains one active pharmaceutical ingredient (API):

1 Tirzepatide UNII OYN3CCI6QE - TIRZEPATIDE

Tirzepatide is a long acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic α and β endocrine cells, brain, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. The activity of tirzepatide on the GIP receptor is similar to native GIP hormone. Tirzepatide improves glycaemic control by lowering fasting and postprandial glucose concentrations in patients with type 2 diabetes through several mechanisms. Read about Tirzepatide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MOUNJARO Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BX16		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02532891, 02532905, 02532913, 02532921, 02532948, 02532956
Country: EE	Ravimiamet	Identifier(s): 1894473, 1894484, 1894495, 1894507, 1894518, 1894529, 1894530, 1894541, 1894552, 1894563, 1894574, 1894585, 1894596, 1894608, 1894619, 1894620, 1894631, 1894642
Country: FR	Base de données publique des médicaments	Identifier(s): 60930150, 61022011, 63816465, 63925443, 64061756, 67657964
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9229, 9230, 9231, 9232, 9233, 9234
Country: IT	Agenzia del Farmaco	Identifier(s): 050357019, 050357021, 050357033, 050357045, 050357058, 050357060, 050357072, 050357084, 050357096, 050357108, 050357110, 050357122, 050357134, 050357146, 050357159, 050357161, 050357173, 050357185
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499422G1024, 2499422G2020, 2499422G3027, 2499422G4023, 2499422G5020, 2499422G6026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1095600, 1095601, 1095602, 1095603, 1095604, 1095605, 1095606, 1095607, 1095608, 1095609, 1095610, 1095611, 1095612, 1095613, 1095614, 1095615, 1095616, 1095617
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69218001, W69218002, W69218003, W69219001, W69219002, W69219003, W69220001, W69220002, W69220003, W69221001, W69221002, W69221003, W69222001, W69222002, W69222003, W69223001, W69223002, W69223003
Country: US	FDA, National Drug Code	Identifier(s): 0002-1457, 0002-1460, 0002-1471, 0002-1484, 0002-1495, 0002-1506